For decades, the patch and the piece of gum have stood as the quiet symbols of a smoker's attempt to break free — familiar, imperfect, and often insufficient. A sweeping Cochrane review of 80 trials and nearly 30,000 participants now places nicotine e-cigarettes ahead of these established methods, finding that regulated vaping devices produce meaningfully higher quit rates than conventional nicotine replacement therapy. The finding does not arrive as a simple triumph, but as a carefully bounded one: the evidence applies only to approved, licensed products, and researchers are already looking b
Cochrane Review: E-cigarettes outperform traditional nicotine replacement for smoking cessation
A safer alternative is worth considering when other quit aids have failed
So the review looked at 80 trials. That's a lot of data. What made researchers decide to update it now?
Nine new trials had been published since the last version. In a living review, you keep adding evidence as it emerges. The new data didn't change the main story—e-cigarettes still came out ahead—but it strengthened the certainty of that finding.
Four more quits per 100 people versus nicotine patches. That sounds significant, but is it actually meaningful in the real world?
It is, because we're talking about millions of smokers. If even a fraction of them switch to e-cigarettes and succeed, that's a lot of prevented deaths. But it also means 96 out of 100 people still don't quit, regardless of method. Quitting is genuinely hard.
The review emphasizes regulated devices only. Why is that distinction so important?
Because the unregulated market is dangerous. Unlicensed e-cigarettes can have faulty batteries that catch fire, or they contain chemicals nobody's tested. The evidence supporting e-cigarettes doesn't apply to those products at all. It's a critical caveat that gets lost in headlines.
Health organizations still warn about youth addiction and other harms. Does the review address that?
It acknowledges those concerns exist, but the review itself focuses on adults trying to quit smoking. The youth risk is real and separate—that's a different population with different stakes. The authors aren't saying e-cigarettes are harmless; they're saying they're less harmful than smoking.
The researchers are already working on how to help people quit vaping. Does that suggest e-cigarettes aren't meant to be permanent?
Exactly. They're positioning it as a bridge, not a destination. The ideal path would be: cigarettes to e-cigarettes to nothing. But they're realistic—for someone stuck on cigarettes, moving to e-cigarettes is progress worth making.
Le Pouls
- Smoking still claims more than seven million lives each year, and the long-trusted tools of patches and gum have left millions of quit attempts unfinished — creating urgent pressure to find what actually works better.
- The Cochrane review's high-certainty finding — four more successful quits per 100 people using e-cigarettes versus traditional nicotine replacement — disrupts decades of public health consensus about which cessation tools to recommend.
- A market flooded with unlicensed vaping products, youth addiction concerns, and continued WHO caution mean the finding cannot be applied broadly without risk of serious harm from unregulated devices.
- Researchers are drawing a firm line: only FDA- or MHRA-approved, nicotine-containing e-cigarettes carry the evidence behind them, and smokers are urged to consult official regulatory lists before choosing a device.
- The field is already moving toward its next question — how to help people quit vaping itself — positioning e-cigarettes not as a destination but as a harm-reduction bridge on a longer journey.
For decades, the patch and the piece of gum have stood as the quiet symbols of a smoker's attempt to break free — familiar, imperfect, and often insufficient. A sweeping Cochrane review of 80 trials and nearly 30,000 participants now places nicotine e-cigarettes ahead of these established methods, finding that regulated vaping devices produce meaningfully higher quit rates than conventional nicotine replacement therapy. The finding does not arrive as a simple triumph, but as a carefully bounded one: the evidence applies only to approved, licensed products, and researchers are already looking beyond vaping itself toward the longer road of complete nicotine cessation.
A major updated review of smoking cessation research has concluded that nicotine e-cigarettes help more people quit traditional cigarettes than patches, gum, or counseling alone — a finding that carries significant weight given the scale of the evidence behind it.
The Cochrane review examined 80 randomized controlled trials involving nearly 30,000 participants. People using nicotine e-cigarettes quit at rates roughly four percentage points higher than those using conventional nicotine replacement therapy, with the evidence rated high-certainty. Even against non-nicotine e-cigarettes, the advantage held, producing about two additional successful quits per 100 people. For a habit that kills more than seven million people annually — including 1.6 million non-smokers exposed to secondhand smoke — even modest improvements in quit rates carry enormous consequence.
Senior author Dr. Jamie Hartmann-Boyce of the University of Massachusetts Amherst noted that the review's core conclusions held firm even after incorporating nine newly published trials, and that no evidence of increased serious harm from e-cigarette use for cessation was found. Lead author Dr. Nicola Lindson of the University of Oxford framed the value of e-cigarettes in human terms: for people who have tried and failed to quit many times, having another option may be what keeps them trying at all.
But the endorsement is carefully bounded. It applies only to regulated, government-approved devices — not the unlicensed products that crowd the market and may contain unstable batteries, harmful chemicals, or unverified substances. The WHO and other health organizations continue to caution about nicotine exposure and the particular risk of drawing young people into new addictions.
Researchers are already looking past the current finding. Hartmann-Boyce is working on a separate review focused on helping people quit vaping itself, treating e-cigarettes as a transitional tool rather than a final answer — a bridge toward a life free of nicotine entirely.
A comprehensive analysis of smoking cessation methods has found that nicotine e-cigarettes help more people quit traditional cigarettes than patches, gum, or counseling alone—a conclusion that arrives as public health agencies worldwide grapple with how to position vaping in the landscape of harm reduction.
The finding comes from an updated Cochrane review examining 80 randomized controlled trials involving nearly 30,000 participants. Researchers discovered that people using nicotine e-cigarettes achieved quit rates about 4 percentage points higher than those using conventional nicotine replacement therapy like patches and gum. When compared to non-nicotine e-cigarettes, the advantage was smaller but still measurable: roughly 2 additional successful quits per 100 people. The evidence supporting these comparisons was rated high-certainty, meaning the researchers have substantial confidence in the numbers.
The context matters. Smoking kills more than seven million people annually according to the World Health Organization, including 1.6 million non-smokers exposed to secondhand smoke. For decades, nicotine patches and gum have been the standard pharmaceutical approach to helping people break the habit. That e-cigarettes now outperform these established methods represents a significant shift in what evidence suggests works best for many smokers attempting to quit.
Dr. Jamie Hartmann-Boyce, senior author of the review from the University of Massachusetts Amherst, emphasized the consistency of the findings. "We have very strong evidence that regulated nicotine e-cigarettes are substantially less harmful than smoking," she said, noting that the review's main conclusions remained unchanged even after incorporating nine newly published trials. The researchers found no evidence of increased serious harm from using e-cigarettes for smoking cessation, though they acknowledged that longer-term studies are still needed to fully understand the safety profile.
Yet the endorsement comes with crucial caveats. The review's conclusions apply only to regulated, nicotine-containing devices that have been tested and approved by government bodies like the FDA in the United States or the MHRA in the United Kingdom. The market is flooded with unlicensed products that may contain unstable batteries, harmful chemicals, or substances like THC. Hartmann-Boyce warned that anyone considering e-cigarettes for smoking cessation should purchase only from approved regulatory lists. Major health organizations, including the WHO, continue to caution that e-cigarettes expose users to nicotine and other chemicals, and that youth use raises particular concerns about creating new nicotine addictions.
Dr. Nicola Lindson, the review's lead author at the University of Oxford, framed the finding in terms of persistence. Many people who smoke have tried quitting multiple times without success, she noted. Having multiple options available—including e-cigarettes—may encourage people to keep attempting to quit rather than giving up entirely. The comparison that matters most, she emphasized, is not whether e-cigarettes are risk-free, but whether they are less harmful than smoking tobacco, which they are.
The researchers view e-cigarettes not as an endpoint but as a stepping stone. Hartmann-Boyce is currently working on a separate review examining how to help people quit vaping itself, positioning nicotine e-cigarettes as a transitional tool in a longer journey toward complete nicotine cessation. For someone already addicted to nicotine through cigarettes, a safer alternative may be worth considering when other quit aids have failed. The next frontier, it seems, is helping people move beyond vaping altogether.
Citations marquantes
We have very strong evidence that regulated nicotine e-cigarettes are substantially less harmful than smoking, and they are a proven and viable option for people wishing to quit traditional cigarettes.— Dr. Jamie Hartmann-Boyce, University of Massachusetts Amherst
For that reason, it is important that there are a number of different options available to help somebody quit, which could encourage them to keep trying.— Dr. Nicola Lindson, University of Oxford